Richard C. Mulligan's most recent trade in Sana Biotechnology Inc was a trade of 80,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sana Biotechnology Inc | Richard C. Mulligan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Bausch Health Companies Inc | Richard C. Mulligan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2025 | 54,347 | 155,616 (0%) | 0% | 0 | Common Shares, No Par Value | |
| Sana Biotechnology Inc | Richard C. Mulligan | Director | Sale of securities on an exchange or to another person at price $ 4.08 per share. | 24 Sep 2024 | 150,000 | 2,848,121 | - | 4.1 | 612,570 | Common Stock |
| Sana Biotechnology Inc | Richard C. Mulligan | Director | Sale of securities on an exchange or to another person at price $ 3.89 per share. | 24 Sep 2024 | 150,000 | 2,698,121 | - | 3.9 | 583,170 | Common Stock |
| Sana Biotechnology Inc | Richard C. Mulligan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Sana Biotechnology Inc | Richard C. Mulligan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 54,278 | 54,278 | - | - | Stock Option (Right to Buy) | |
| Bausch Health Companies Inc | Richard C. Mulligan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 35,360 | 101,269 (0%) | 0% | 0 | Common Shares, No Par Value | |
| Sana Biotechnology Inc | Richard C. Mulligan | Director, Head of SanaX | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 200,000 | 200,000 | - | - | Stock Options (Right to Buy) | |
| Biogen | Richard C. Mulligan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 1,370 | 15,099 (0%) | 0% | 0 | Common Stock | |
| Sana Biotechnology Inc | Richard C. Mulligan | Director, Head of SanaX | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 250,000 | 250,000 | - | - | Stock Options (Right to Buy) | |
| Biogen | Richard C. Mulligan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 775 | 13,729 (0%) | 0% | 0 | Common Stock |